
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 中德证券有限责任公司关于天域生态环境股份有限公司非公开发行股票的保荐总结报告书 | 2023-05-10 | Chinese | |
| 2022年年度股东大会会议资料 | 2023-05-08 | Chinese | |
| 独立董事关于第四届董事会第十五次会议相关议案的独立意见 | 2023-05-05 | Chinese | |
| 天域生态关于未弥补亏损达到实收股本总额三分之一的公告 | 2023-05-05 | Chinese | |
| 天域生态环境股份有限公司前次募集资金使用情况鉴证报告 | 2023-05-05 | Chinese | |
| 天域生态关于召开2022年度业绩说明会暨问题征集的公告 | 2023-05-05 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 38188295 | 中德证券有限责任公司关于天域生态环境股份有限公司非公开发行股票的保荐总结报告书 | 2023-05-10 | Chinese | ||
| 38188277 | 2022年年度股东大会会议资料 | 2023-05-08 | Chinese | ||
| 38188237 | 独立董事关于第四届董事会第十五次会议相关议案的独立意见 | 2023-05-05 | Chinese | ||
| 38188216 | 天域生态关于未弥补亏损达到实收股本总额三分之一的公告 | 2023-05-05 | Chinese | ||
| 38188193 | 天域生态环境股份有限公司前次募集资金使用情况鉴证报告 | 2023-05-05 | Chinese | ||
| 38188081 | 天域生态关于召开2022年度业绩说明会暨问题征集的公告 | 2023-05-05 | Chinese | ||
| 38188064 | 天域生态关于2022年年度股东大会增加临时提案的公告 | 2023-05-05 | Chinese | ||
| 38188030 | 天域生态前次募集资金使用情况的专项报告 | 2023-05-05 | Chinese | ||
| 38188014 | 德恒上海律师事务所关于天域生态环境股份有限公司2022年股票期权激励计划首次授予部分第一个行权期行权条件成就及注销部分股票期权相关事项的法律意见书 | 2023-04-28 | Chinese | ||
| 38187983 | 天域生态关于2022年股票期权激励计划首次授予股票期权第一个行权期行权条件成就的公告 | 2023-04-28 | Chinese | ||
| 38187970 | 天域生态关于会计政策变更的公告 | 2023-04-28 | Chinese | ||
| 38187956 | 独立董事关于第四届董事会第十四次会议相关议案的独立意见 | 2023-04-28 | Chinese | ||
| 38187938 | 中德证券有限责任公司关于天域生态环境股份有限公司2022年度持续督导报告书 | 2023-04-28 | Chinese | ||
| 38187915 | 2022年内部控制评价报告 | 2023-04-28 | Chinese | ||
| 38187881 | 天域生态环境股份有限公司2022年度内部控制审计报告 | 2023-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.